Tesaro - Moonstone for Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
- Have relapsed ovarian, Fallopian tube, or primary peritoneal cancer
- Have had no more than 3 prior treatments for your cancer
What is Involved?
If you choose to join this study you will:
- Take the study drug (Niraparib) for 3 weeks
- Get an infusion (into your vein) of the study drug (TSR-042) once a week for 3 months
- Get a physical every 3 weeks